AquaBounty Technologies. with ticker code (AQB) have now 4 market analysts covering the stock. The analyst consensus now points to a rating of ‘Buy’. The range between the high target price and low target price is between 4.5 and 1.79 and has a mean target at $2.95. Now with the previous closing price of $.58 this would indicate that there is a potential upside of 408.6%. It’s also worth noting that there is a 50 day moving average of $.85 and the 200 moving average now moves to $1.03. The company has a market capitalization of $42m. Visit the company website at: https://www.aquabounty.com
The potential market cap would be $211m based on the market consensus.
AquaBounty Technologies., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms. and changed its name to AquaBounty Technologies. in June 2004. AquaBounty Technologies. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
The company is not paying dividends at this time.
